InsiderClue
Insiders · Profile

Calias Pericles

Chief Scientific Officer at Avalo Therapeutics. Filing since 10 Jun 2019. CIK 0001746282

Company
Date
Role
Action
Shares
Amount
Of holding
AVTX Avalo Therapeutics, Inc.
10 Dec 2019
Chief Scientific Officer
Bought
2,913
$8.29K
5.9%
AVTX Avalo Therapeutics, Inc.
10 Jun 2019
Chief Scientific Officer
Bought
4,549
$12.95K
10.1%
2 decisions on file.